interleukin-2
[용어속성] Protein
Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection
Article
[키워드] assays
BNT162b2
BNT162b2 vaccine
class
correlated
demonstrated
develop
dose
doses
epitope
exhibited
Frequency
greater
healthcare worker
healthy
IFN-γ
IgG response
IL-2
IL2
Immunity
individual
infected with SARS-CoV-2
Infection
Interferon-gamma
interleukin-2
magnitude
Moderna mRNA-1273 vaccine
mononuclear cell
mRNA-1273
N and M
nine
participant
Participants
PCR testing
peptide
Peripheral blood
Pfizer-BioNTech
positive
Post-infection
Proteins
proteome
repeated
responders
response
responses against
robust
S glycoprotein
S1 and S2
S2 subunit
SARS-CoV-2
SARS-COV-2 infection
structural protein
subunit
subunits
T cell response
T-cell Response
the SARS-CoV-2
uninfected
vaccination
vaccinee
was determined
were expressed
with COVID-19
[DOI] 10.1371/journal.pone.0276241 PMC 바로가기
[DOI] 10.1371/journal.pone.0276241 PMC 바로가기
In Vitro Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19
다클론 자극에 대한 1차 인간 T 세포 및 단핵구의 체외 노출은 손상된 세포 면역 반응을 표시하고 심각한 COVID-19를 발생시키는 기초 감수성을 나타냅니다
Article
[키워드] (PD-1
acute respiratory syndrome
acute respiratory syndrome coronavirus
Alpha
analyzed
Anosmia
anti-CD3
Antibody titer
Antibody titers
basal
baseline characteristics
biochemical
blood sample
Blood samples
CD14
CD16
CD4+
CD8+ T cell
CD8+ T cells
Cellular immune response
cellular immunity
classical
classical monocytes
clinical recovery
conducted
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 progression
disease
display
distress
drug
Evidence
exposure
expression
Fever
Follow-up
headache
healthy volunteer
Human
Humoral immunity
hypoxia
IFN-alpha
IFN-gamma
IL-2
immune function
immune response
Immunoglobulin
Immunoglobulin G
Impaired
in vitro
interferon
interleukin
interleukin-2
Invasive mechanical ventilation
lipopolysaccharide
Mild
mild cases
monocyte
monocyte subsets
Monocytes
Neutralizing
no difference
no differences
non-classical monocyte
Non-classical monocytes
not differ
participant
Patient
PD-1
Pneumonia
polyclonal
predisposition
programmed cell death
programmed cell death protein
prospective cohort study
Protein
receiving
Registered
required
respiratory
respiratory distress
response
S1 protein
SARS-CoV-2
SARS-COV-2 infection
serum titer
Severe case
severe cases
severe COVID-19
severity
significantly
subset
Symptom
T cell
T cells
virus
worsening
[DOI] 10.3389/fimmu.2022.897995 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.897995 PMC 바로가기 [Article Type] Article
Clinical progress in MSC-based therapies for the management of severe COVID-19
Mini review
[키워드] MB-MSCs
Menstrual blood-derived Mesenchymal Stromal Cells
3-dioxygenase
ACE2angiotensin converting enzyme 2
acute graft-versus-host disease
acute respiratory distress syndrome
Adipose Tissue derived Mesenchymal Stromal Cells
admadministration
administration
alanine aminotransferase
Allo-MSCsAllogeneic Mesenchymal Stromal Cells
Alloallogeneic
Allogeneic
Allogeneic Mesenchymal Stromal Cells
ALTalanine aminotransferase
angiotensin converting enzyme 2
anti-inflammatory property
ARDS
ARDSacute respiratory distress syndrome
Aspartate aminotransferase
ASTaspartate aminotransferase
AT-MSCsAdipose Tissue derived Mesenchymal Stromal Cells
AT2type 2 alveolar cells of the lungs
BALFbronchoalveolar lavage fluid
BM-MSCsbone marrow derived MSCs
body weight
bone marrow derived MSCs
Bronchoalveolar lavage fluid
bwBody weight
C-reactive protein
cAMPcyclic adenosine monophosphate
candidate
CDcluster of differentiation
Cell
clinical
clinical trial
cluster of differentiation
complex
conducted
Coronavirus disease 2019
coronavirus disease of 2019
COVID-19
COVID-19Coronavirus disease of 2019
CRPC-reactive protein
cyclic adenosine monophosphate
cytokine
Daewoong Pharmaceutical’s Mesenchymal Stromal Cells
DCsdendritic cells
dendritic cells
driven by
DSCsPlacenta-derived decidua stromal cells
DW-MSCsDaewoong Pharmaceutical’s Mesenchymal Stromal Cells
EVsextracellular vesicles
Extracellular vesicles
Fas ligands
Fas-LFas ligands
FDAFood and Drug Administration
FGFfibroblast growth factor
fibroblast growth factor
Food and Drug Administration
forkhead box P3 +
FOXP3 +forkhead box P3 +
G-CSFgranulocyte colony-stimulating factor
Gal-1galectin-1
Gal-3galectin-3
Gal-9galectin-9
galectin-1
galectin-3
Galectin-9
GM-CSFgranulocyte macrophage-colony stimulating factor
granulocyte colony-stimulating factor
granulocyte macrophage-colony stimulating factor
growth factor
GvHDacute graft-versus-host disease
HB-AT-MSCsHope Biosciences autologous adipose-derived mesenchymal stromal cells
HdHigh dose
hepatocyte growth factor
HGFhepatocyte growth factor
High dose
HLAHuman leukocyte antigen
Hope Biosciences autologous adipose-derived mesenchymal stromal cells
human leukocyte antigen
ICUIntensive Care Unit
IDOIndoleamine 2
IFN-γinterferon-γ
IL-10interleukin-10
IL-1interleukin-1
IL-1βinterleukin-1β
IL-2 receptor
IL-2interleukin-2
IL-2RIL-2 receptor
IL-4interleukin-4
IL-6interleukin-6
IL-7Interleukin 7
IL-7interleukin-7
IL-8interleukin 8
IL-9interleukin
IL1-αinterleukin 1-α
IL1-βinterleukin 1-β
IL1RaInterleukin-1 receptor antagonist
immune dysregulation
immunological
immunomodulatory
IMVInvasive mechanical ventilation
Indoleamine 2
inducible protein 10
inflammatory process
inhalation
INHinhalation
intensive care unit
interferon-γ
interleukin
interleukin 1-α
interleukin 1-β
Interleukin 7
interleukin 8
interleukin-1
Interleukin-1 receptor antagonist
interleukin-10
interleukin-1β
interleukin-2
Interleukin-4
interleukin-6
interleukin-7
intravenous
Invasive mechanical ventilation
IP-10inducible protein 10
IVintravenous
keratinocyte growth factor
KGFkeratinocyte growth factor
lactate dehydrogenase
LDHlactate dehydrogenase
LdLow dose
lipopolysaccharide
low dose
LPSlipopolysaccharide
major histocompatibility complex
management
MAPKmitogen-activated protein kinase
MCP-1monocyte chemoattractant protein-1
Mesenchymal stromal cell
Mesenchymal stromal cells
MHCMajor Histocompatibility Complex
microRNA
miRNAmicroRNA
MIS-Cmultisystem inflammatory syndrome in children
mitogen-activated protein kinase
monocyte chemoattractant protein-1
MSCs
MSCsmesenchymal stromal cells
multisystem inflammatory syndrome in children
nanovesicles
National Institutes of Health
natural
NETsNeutrophil Extracellular Traps
Neutrophil extracellular traps
NF-κBnuclear factor-kappa B
NIHNational Institutes of Health
nitric oxide
NKnatural
NONitric Oxide
nuclear factor-kappa B
NVsnanovesicles
occur
PD-1programmed cell death protein 1
PD-L1programmed death ligand-1
PGE2prostaglandin E2
pharmacological management
PL-MSCsPlacental-derived Mesenchymal Stromal Cells
Placenta-derived decidua stromal cells
placental expanded
Placental-derived Mesenchymal Stromal Cells
PLX-PADplacental expanded
programmed cell death protein 1
programmed death ligand-1
prostaglandin E2
protein spike
public health
reactive oxygen species
Regulatory T cell
Respiratory failure
RFrespiratory failure
ROSreactive oxygen species
SARS-CoV-2severe acute respiratory syndrome coronavirus 2
Secretome
severe acute respiratory syndrome coronavirus 2
severe COVID-19
Severe respiratory distress
signal transducer activators of transcription-3
Sprotein spike
STAT3signal transducer activators of transcription-3
syndrome
TGF-β1transforming growth factor-β1
TGFtransforming growth factor
the cytokine storm
the disease
therapeutic
therapy
TLRtoll-like receptors
TNF-α-stimulating gene 6
TNF-αtumor necrosis factor-α
TNFTumor Necrosis Factor
Toll-like receptors
transforming growth factor
transforming growth factor-β1
treat
Tregregulatory T cell
TSG-6TNF-α-stimulating gene 6
tumor necrosis factor
tumor necrosis factor-α
type 2 alveolar cells of the lungs
UC-MSCsumbilical cord derived MSCs
umbilical cord derived MSCs
vascular endothelial growth factor
VEGFvascular endothelial growth factor
Wharton’s Jelly–derived Mesenchymal Stromal Cells
WJ-MSCsWharton’s Jelly–derived Mesenchymal Stromal Cells
[DOI] 10.1016/j.cytogfr.2022.07.002 [Article Type] Mini review
[DOI] 10.1016/j.cytogfr.2022.07.002 [Article Type] Mini review
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study
COVID-19에서 회복된 사람들의 감염 1년 후 SARS-CoV-2-특이 항체 및 T-세포 반응: 종단 코호트 연구
Article
Published on
Journal: The Lancet. Microbe [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, 치료기술,
Journal: The Lancet. Microbe [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, 치료기술,
[키워드] Academy
age
analysed
antibody
Antibody Response
antibody titres
B.1.351
B.1.617.2
Beta
Beta variant
breadth
caused
center
Chinese
collected
communicable disease
Communicable Disease Diagnosis
COVID-19
Critical
cross-reactive
cytokine
cytokine profile
D614G
D614G variant
delta variant
Delta variants
detect
detectable
discharged
disease
disease severity
ELISA
ELISPOT
enrolled
enzyme
evaluated
Follow-up
Follow-up visit
follow-up visits
foundation
humoral
humoral and T-cell response
ICS
IFN-γ
IFNγ
IgA
IgG antibodies
IgG antibody
IgM
IL-2
immune
immune response
In-vitro
individual
individuals
Infection
initial
interferon
interferon γ
interleukin
interleukin-2
intracellular cytokine staining
longitudinal cohort study
magnitude
Medical Research Council
Medical Sciences
memory
memory immune response
memory T-cell response
memory T-cell responses
microneutralisation assay
natural
Necrosis
neutralising
Neutralising Antibodies
neutralising antibody
neutralising antibody response
Neutralising antibody responses
neutralising antibody titre
neutralising antibody titres
no difference
not disrupted
participant
Patient
patients
patients with moderate
PBMC
PBMCs
plasma
plasma sample
plasma samples
Protein
Receptor-binding domain
recovered patient
recovered patients
recruited
reduce
reduced
reducing
reduction
Reinfection
remained
retained
robustness
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 nucleoprotein
SARS-CoV-2 strain
SARS-CoV-2 viral
SARS-CoV-2-specific T-cell response
Science
severe disease
spike
Spike protein
subset
symptom severity
Symptoms
T-cell Response
T-cell responses
tested
the interferon
the receptor-binding domain
the SARS-CoV-2
titre
TNFα
tumour necrosis factor
Tumour Necrosis Factor α
variant
variants
variants of concern
Viral proteins
viral strain
viral strains
Wuhan
Wuhan, China
[DOI] 10.1016/S2666-5247(22)00036-2 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/S2666-5247(22)00036-2 PMC 바로가기 [Article Type] Article
Liver Injury and Elevated Levels of Interleukins, Interleukin-2 Receptor, and Interleukin-6 Predict the Severity in Patients With COVID-19
Public Health
[키워드] acute respiratory syndrome
addition
association
caused
Characteristics
clinical
clinician
coronavirus
COVID-19
Diagnosis
disorder
Epidemiology
feature
IL-2R
IL-6
infected with SARS-CoV-2
information
interleukin-2
interleukin-6
Interleukins
Level
liver
liver dysfunction
Liver function
Liver injury
novel coronavirus disease
pandemic
Patient
patients
patients with COVID-19
predict
Prognosis
prognosis of patient
receptor
SARS-CoV-2
Severe patient
severity of COVID-19
Spread
the WHO
Treatment
with COVID-19
[DOI] 10.3389/fpubh.2021.778340 PMC 바로가기 [Article Type] Public Health
[DOI] 10.3389/fpubh.2021.778340 PMC 바로가기 [Article Type] Public Health
Immunomodulatory effects of Andrographis paniculata extract in healthy adults – An open-label study
Original Research Article (Clinical)
[키워드] Andrographis paniculata
Immunity
interferon gamma
interleukin-2
Interleukin-4
T cells
T helper cells
[DOI] 10.1016/j.jaim.2021.06.004 PMC 바로가기 [Article Type] Original Research Article (Clinical)
[DOI] 10.1016/j.jaim.2021.06.004 PMC 바로가기 [Article Type] Original Research Article (Clinical)
Elevations in Liver Transaminases in COVID-19: (How) Are They Related?
Medicine
[키워드] Admission
Altered
analyzed
association
borderline
Clinical data
complementary
COVID-19
cross-sectional
CRP
death
demographic
described
disease severity
Elevation
elevations
greater
group
Hepatitis
ICU
IL-10
IL-2
immune response
Inflammation
Inflammatory cytokine
inflammatory parameter
interleukin-10
interleukin-2
liver
liver transaminase
Lymphocytes
marker
Mild
NEWS2
normal
occur
parameter
patients with COVID-19
SARS-CoV-2
Serum level
severe disease
transaminase
transaminases
viral infection
with COVID-19
[DOI] 10.3389/fmed.2021.705247 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.705247 PMC 바로가기 [Article Type] Medicine